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Abstract
The epithelial components of the mammary gland are thought to
arise from a stem cell capable of both self-renewal and multi-
lineage differentiation. Furthermore, there is increasing evidence
that mammary carcinomas originate in these cells or their
immediate progeny. The recent identification of murine mammary
stem cells should facilitate their molecular characterization and
help to elucidate their role in mammary carcinogenesis. In addition,
an understanding of the biology of these cells including the
pathways that regulate their self-renewal and differentiation may
suggest new approaches for the prevention and treatment of
breast cancer.
The recent report by Shackleton and colleagues [1] demon-
strating the generation of a functional mammary gland in the
mouse from a single stem cell has important implications for
understanding mammary development and carcinogenesis.
The existence of stem cells capable of generating the entire
epithelial components of the mammary gland has long been
postulated. Stem cells are defined by their ability to undergo
self-renewal, as well as lineage specific differentiation.
Previous studies providing indirect evidence for the existence
of these cells utilized transplantation of retrovirus tagged
epithelial fragments into the cleared fat pads of recipient mice
[2]. Evidence for the existence of mammary stem and
progenitor cells has also been provided by in vitro studies.
These studies have identified cell populations capable of
giving rise to all three epithelial cell types found in the adult
gland, ductal and alveolar epithelial cells and myoepithelial
cells. Shackleton and colleagues provide more definitive
evidence for the existence of such a stem cell by
prospectively isolating these cells using cell surface markers
and performing transplantation into the cleared mammary fat
pads of syngenic mice. They define a mammary repopulating
unit based on the ability to regenerate a mammary gland in
vivo. Cells that are CD29hiCD24+ Lin– are enriched for this
property. To demonstrate that a single cell contained within
this population is able to reconstitute an entire mammary
gland they used the Rosa-26 mouse carrying a LacZ
transgene, which allows for tagging of donor cells. By
performing serial dilutions as well as transplanting single
marked cells that were confirmed by visual inspection they
calculated that at least one out of 64 cells bearing the
phenotype Lin–CD29hiCD24+ is a stem cell, as defined by its
ability to reconstitute an entire mammary gland.
Studies in haematopoietic stem cell biology have been
greatly facilitated by the development of suitable animal
models in which a single haematopoietic stem cell can
reconstitute the entire haematopoietic system of a lethally
irradiated mouse [3]. Until the present time, comparable in
vivo models did not exist for epithelial stem cells. The study of
Shackleton and colleagues [1] provides the first model
system in which the epithelial components of an entire organ
can be generated in vivo from a single cell. Both the studies
of Shackleton and colleagues [1] and similar studies reported
by Stingl and colleagues [4] demonstrate that these cells
also display the second defining property of stem cells, the
ability to self-renew. To demonstrate this, they performed
serial transplantation of mammary repopulating units,
calculating that a single mammary repopulating cell is
capable of executing at least ten symmetrical self-renewal
divisions.
Recent studies have suggested the existence of stem cells in
the human mammary gland similar to those in the rodent.
These studies have largely consisted of in vitro
characterization of cells that could give rise to multiple
lineages. We demonstrated that non-adherent mammo-
spheres are highly enriched for cells with stem and progenitor
cell properties [5]. The ability to transplant human mammary
cells into the rodent mammary gland was advanced by the
work of Kuperwasser and colleagues [6]. They demonstrated
that human mammary epithelial cells could be grown in fat
pads of NOD/SCID mice that were humanized by human
mammary stromal cells. Building on this work, we have
recently reported that mammospheres can regenerate human
mammary glands in such a model [7]. These studies highlight
the importance of stromal-epithelial interactions in regulating
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mammary stem cell self-renewal and differentiation. These
interactions define a stem cell ‘niche’. This niche is thought to
be composed of both cellular as well as extracellular
elements. It is postulated that stem cells receive paracrine
signals from ‘niche’ cells that regulate stem cell behavior,
including self-renewal and differentiation. The nature of the
stem cell ‘niche’ that regulates behavior of normal and
malignant mammary stem cells has recently been reviewed by
Bissell and colleagues [8] and Li and colleagues [9]. The
ability to transplant both murine and human cells into such a
‘niche’ should allow the further elucidation of key regulatory
pathways for stem cell self-renewal and lineage specific
differentiation.
The isolation and characterization of mammary stem cells also
has important implications for understanding mammary
carcinogenesis. Recent studies in the mammary gland and
other organs have given impetus to the ‘cancer stem cell
hypothesis’, which has two interrelated components. The first
is that cancers arise from stem cells or their immediate
progeny, and the second is that tumors contain a hierarchy of
cells, including ‘cancer stem cells’ that drive tumorigenesis
[10]. The study of Shackleton and colleagues [1] supports
such a model. They examined the percentage of cells
expressing the stem cell phenotype Lin–CD29hiCD24+ in
MMTV-wnt transgenic mice. It has previously been shown
that these mice develop carcinomas containing cells that
display markers of both epithelial and myoepithelial lineages
[11]. Shackleton and colleagues report that there was a
6.4-fold increase in the absolute number of cells bearing the
stem cell phenotype in these mice. Wnt signaling has been
shown to play a role in the self-renewal of several normal
stem cells [12]. Interestingly, when Shackleton and
colleagues transplanted CD29hiCD24+ cells from these
transgenic mice into cleared fat pads of wild-type recipients,
the recipients produced hyperplastic outgrowths. This is
consistent with the stem cell model in which perturbation of
the self-renewal of stem cells gives rise to stem cell
expansion and hyperplasia, which in turn provides targets for
further transforming events [10]. Indeed, we have found that
disruption of Hedgehog signaling in normal human mammary
stem/progenitor cells results in the generation of ductal
hyperplasia when these cells are transplanted into the
humanized cleared fat pads of NOD/SCID mice [7].
Interestingly, expansion of the stem cell compartment was not
seen in MMTV-neu mice, which develop luminal tumors.
These studies suggest that, while MMTV-wnt affects a
primitive mammary cell, MMTV-neu affects a more committed
epithelial specific progenitor. These studies are also
consistent with our recent characterization of stem cells in
human breast cancer, which are characterized as
CD44+CD24loLin– [13]. Both Shackelton and colleagues and
Stingl and colleagues localized the majority of mammary
repopulating cells to the basal compartment in the normal
gland, while human breast cancer cells express CD44, a
basal marker [13]. This suggests that there may be a link
between normal and tumorigenic breast stem cells. In
addition, transformation of different mammary stem or
progenitor cells may account for the different molecular
subtypes of breast cancer detected in molecular profiling
studies [14]. It remains unclear whether markers utilized to
identify normal and malignant mammary stem cells play a
functional role. CD29 and CD49 recognize alpha-6 beta-1
integrin, a molecule that has also been described as
expressed in other stem cells. This integrin may play a role in
anchoring stem cells in the stem cell ‘niche’. CD44 is a
receptor for haluronic acid, which has been shown to play a
role in tumor migration and metastasis [15]. CD24 has
recently been described as a negative regulator of CXCR4, a
cytokine receptor important in facilitating breast cancer
metastasis [16]. Interestingly, although the studies of
Shackelton and colleagues suggest that murine repopulating
cells are CD24+, more recent studies by this group and
others have suggested that high levels of CD24 are
expressed on luminal precursors, whereas an intermediate
level of expression is found on more primitive mammary
repopulating cells [17]. In the studies by Shakelton and
colleagues, as well as our own studies, cells displaying
lineage specific markers were eliminated to further enrich the
stem cell populations. Together, these studies suggest that
there are important similarities between markers expressed
by both normal and tumorigenic mammary stem cells.
Furthermore, these markers may play a functional role in stem
cell behavior.
The further identification of markers that identify cells at
different stages of mammary development should greatly
facilitate our understanding of normal development and
carcinogenesis. An understanding of the biology of the cells
that drive tumorogenesis has the potential to lead to new
therapeutic approaches for breast cancer.
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